Australia's largest stock trading and investment forum Australia's #1 stock forum

CDX cardiex limited

2.50%

3.9¢

Not the first time.Ive previously had to email them to check a...

First 348 Last

Share
Profile

Follow
kickit2me

13,677 Posts.

4921

11/02/21

20:50

Post #: 50912357
Share

Originally posted by Quiltman: ↑

Oh dear, I suspect today's sell-off may be linked to poor communication around the launch timing for our smartwatch, which is end of FY Q3/start Q4 ( end of March, early April 2021). This has been referred to numerous times in many presentations. See below

However, in the quarterly activities report, it was mistakenly poorly communicated as :

No FDA clearance is required for the Company’s first wearable product launch in partnership with
Mobvoi – which is on track for Q4 2021.

IT IS Q4 of the FY 20/21, not the calendar year 2021.

As a result, this has been mis-represented in this *****head report published this morning :
https://*****head.com.au/health/medical-devices-tracker-all-the-life-saving-gadgets-asx-companies-are-working-on-right-now/

Anyone without in depth knowledge of CDX. reading this, can only assume it has been delayed.

I actually think Craig needs to re-inform the market of correct dates before things get out of hand.

Expand

Not the first time.

Ive previously had to email them to check a similar ambiguity.

Needs to be written in full: Q4FY21 or Q2CY21 ...every time.

...

CDX Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 348 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $17.49M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$20.01K	521.6K

Buyers (Bids)

No.	Vol.	Price($)
2	75000	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	60000	1

View Market Depth

No.	Vol.	Price($)
2	75000	0.038
5	677100	0.037
2	263210	0.036
4	515503	0.035
3	382970	0.034

Price($)	Vol.	No.
0.042	60000	1
0.045	82414	2
0.050	100000	1
0.052	180000	1
0.080	100799	1

Last trade - 15.40pm 27/06/2025 (20 minute delay)

CDX (ASX) Chart

Not the first time.Ive previously had to email them to check a...

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Not the first time.Ive previously had to email them to check a...

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News